BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

604 related articles for article (PubMed ID: 19780621)

  • 41. Synthesis and structure of ruthenium(IV) complexes featuring N-heterocyclic ligands with an N-H group as the hydrogen-bond donor: hydrogen interactions in solution and in the solid state.
    Díez J; Gimeno J; Merino I; Rubio E; Suárez FJ
    Inorg Chem; 2011 Jun; 50(11):4868-81. PubMed ID: 21557560
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Coordinatively diverse ortho-phosphinoaniline complexes of ruthenium and isolation of a putative intermediate in ketone transfer hydrogenation catalysis.
    Hounjet LJ; Bierenstiel M; Ferguson MJ; McDonald R; Cowie M
    Inorg Chem; 2010 May; 49(9):4288-300. PubMed ID: 20364836
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis, characterization, and in vitro evaluation of novel ruthenium(II) eta6-arene imidazole complexes.
    Vock CA; Scolaro C; Phillips AD; Scopelliti R; Sava G; Dyson PJ
    J Med Chem; 2006 Sep; 49(18):5552-61. PubMed ID: 16942028
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of chelating ligands to tune the reactive site of half-sandwich ruthenium(II)-arene anticancer complexes.
    Fernández R; Melchart M; Habtemariam A; Parsons S; Sadler PJ
    Chemistry; 2004 Oct; 10(20):5173-9. PubMed ID: 15372674
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Derivation of structure-activity relationships from the anticancer properties of ruthenium(II) arene complexes with 2-aryldiazole ligands.
    Martínez-Alonso M; Busto N; Jalón FA; Manzano BR; Leal JM; Rodríguez AM; García B; Espino G
    Inorg Chem; 2014 Oct; 53(20):11274-88. PubMed ID: 25302401
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Highly active neutral ruthenium(II) arene complexes: synthesis, characterization, and investigation of their anticancer properties.
    Ludwig G; Kaluđerović GN; Bette M; Block M; Paschke R; Steinborn D
    J Inorg Biochem; 2012 Aug; 113():77-82. PubMed ID: 22698819
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Contrasting cellular uptake pathways for chlorido and iodido iminopyridine ruthenium arene anticancer complexes.
    Romero-Canelón I; Pizarro AM; Habtemariam A; Sadler PJ
    Metallomics; 2012 Dec; 4(12):1271-9. PubMed ID: 23138378
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Heteroleptic arene ruthenium complexes based on meso-substituted dipyrrins: synthesis, structure, reactivity, and electrochemical studies.
    Yadav M; Singh AK; Maiti B; Pandey DS
    Inorg Chem; 2009 Aug; 48(16):7593-603. PubMed ID: 19610658
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Competition between glutathione and guanine for a ruthenium(II) arene anticancer complex: detection of a sulfenato intermediate.
    Wang F; Xu J; Habtemariam A; Bella J; Sadler PJ
    J Am Chem Soc; 2005 Dec; 127(50):17734-43. PubMed ID: 16351102
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Areneruthenium(II) 4-acyl-5-pyrazolonate derivatives: coordination chemistry, redox properties, and reactivity.
    Marchetti F; Pettinari C; Pettinari R; Cerquetella A; Cingolani A; Chan EJ; Kozawa K; Skelton BW; White AH; Wanke R; Kuznetsov ML; Martins LM; Pombeiro AJ
    Inorg Chem; 2007 Oct; 46(20):8245-57. PubMed ID: 17727269
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Maltol-derived ruthenium-cymene complexes with tumor inhibiting properties: the impact of ligand-metal bond stability on anticancer activity in vitro.
    Kandioller W; Hartinger CG; Nazarov AA; Bartel C; Skocic M; Jakupec MA; Arion VB; Keppler BK
    Chemistry; 2009 Nov; 15(45):12283-91. PubMed ID: 19821465
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Arene-ruthenium complexes of an acyclic thiolate-thioether and tridentate thioether derivatives resulting from ring-closure reactions.
    Shin RY; Bennett MA; Goh LY; Chen W; Hockless DC; Leong WK; Mashima K; Willis AC
    Inorg Chem; 2003 Jan; 42(1):96-106. PubMed ID: 12513082
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hydrocarbon oxidation by beta-halogenated dioxoruthenium(VI) porphyrin complexes: effect of reduction potential (RuVI/V) and C-H bond-dissociation energy on rate constants.
    Che CM; Zhang JL; Zhang R; Huang JS; Lai TS; Tsui WM; Zhou XG; Zhou ZY; Zhu N; Chang CK
    Chemistry; 2005 Nov; 11(23):7040-53. PubMed ID: 16163758
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A potent ruthenium(II) antitumor complex bearing a lipophilic levonorgestrel group.
    Ruiz J; Rodríguez V; Cutillas N; Espinosa A; Hannon MJ
    Inorg Chem; 2011 Sep; 50(18):9164-71. PubMed ID: 21830785
    [TBL] [Abstract][Full Text] [Related]  

  • 55. DNA interactions of monofunctional organometallic ruthenium(II) antitumor complexes in cell-free media.
    Novakova O; Chen H; Vrana O; Rodger A; Sadler PJ; Brabec V
    Biochemistry; 2003 Oct; 42(39):11544-54. PubMed ID: 14516206
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of bimetallic titanocene-ruthenium-arene complexes as anticancer agents: relationships between structural and biological properties.
    Pelletier F; Comte V; Massard A; Wenzel M; Toulot S; Richard P; Picquet M; Le Gendre P; Zava O; Edafe F; Casini A; Dyson PJ
    J Med Chem; 2010 Oct; 53(19):6923-33. PubMed ID: 20822096
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Organo-ruthenium supported heteropolytungstates: synthesis, structure, electrochemistry, and oxidation catalysis.
    Bi LH; Al-Kadamany G; Chubarova EV; Dickman MH; Chen L; Gopala DS; Richards RM; Keita B; Nadjo L; Jaensch H; Mathys G; Kortz U
    Inorg Chem; 2009 Nov; 48(21):10068-77. PubMed ID: 19780533
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis, characterization, and photochemical behavior of {Ru(arene)}2+ derivatives of alpha-[PW11O39]7-: an organometallic way to ruthenium-substituted heteropolytungstates.
    Artero V; Laurencin D; Villanneau R; Thouvenot R; Herson P; Gouzerh P; Proust A
    Inorg Chem; 2005 Apr; 44(8):2826-35. PubMed ID: 15819571
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Conformation of DNA modified by monofunctional Ru(II) arene complexes: recognition by DNA binding proteins and repair. Relationship to cytotoxicity.
    Novakova O; Kasparkova J; Bursova V; Hofr C; Vojtiskova M; Chen H; Sadler PJ; Brabec V
    Chem Biol; 2005 Jan; 12(1):121-9. PubMed ID: 15664521
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Replacement of chlorides with dicarboxylate ligands in anticancer active Ru(II)-DMSO compounds: a new strategy that might lead to improved activity.
    Bratsos I; Serli B; Zangrando E; Katsaros N; Alessio E
    Inorg Chem; 2007 Feb; 46(3):975-92. PubMed ID: 17257042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.